TYRO3 and hepatocellular carcinoma: Experimental data illustrated that miR-7 overexpression could effectively silence TYRO3 expression in sorafenib-sensitive and sorafenib-resistant Huh-7 cells, thereby overcoming sorafenib Table 1 resistance in HCC caused by abnormal TYRO3 expression (Kabir et al., 2018).